Browse Category

Stock Market News 3 December 2025

Home Depot (HD) Stock Today: Q3 2025 Earnings Miss, Dividend Deadline and December 2025 Outlook

Home Depot (HD) Stock Today: Q3 2025 Earnings Miss, Dividend Deadline and December 2025 Outlook

As of Wednesday, December 3, 2025, shares of The Home Depot, Inc. (NYSE: HD) closed at $357.91, up about 1.1% on the day, and roughly 18% below their 52‑week high of $436.36 set in December 2024. Trading volume was slightly above average, reflecting renewed interest after a turbulent November. MarketWatch+1 That renewed interest isn’t random. Over the past few days Home Depot has: Here’s a detailed look at what’s happening with Home Depot stock right now, and how Wall Street is framing the outlook into 2026. 1. Home Depot Stock Price and Performance in December 2025 Data providers differ a
Fiserv (FISV) Stock Jumps on Insider Buying as New Lawsuit and Black Friday Data Define a High-Risk 2025 Turnaround – December 3, 2025 Update

Fiserv (FISV) Stock Jumps on Insider Buying as New Lawsuit and Black Friday Data Define a High-Risk 2025 Turnaround – December 3, 2025 Update

Fiserv, Inc. (NASDAQ: FISV) squeezed out a rare rally on Wednesday, December 3, 2025, even as fresh legal action and mixed macro data kept the fintech giant’s turnaround story firmly in “show me” territory. At the close, Fiserv shares traded around $66.95, up nearly 6% on the day, after touching an intraday high of about $67.70. Volume topped 14.9 million shares, far above the recent average, as traders reacted to sizeable insider buying disclosures and a new securities class‑action lawsuit. StockAnalysis Despite today’s bounce, the stock remains down roughly 70% from its 52‑week high near $238.59, making it one of
3 December 2025
Seagate (STX) Stock on December 3, 2025: Insider Selling, AI Tailwinds and Fresh Wall Street Price Targets

Seagate (STX) Stock on December 3, 2025: Insider Selling, AI Tailwinds and Fresh Wall Street Price Targets

Updated: December 3, 2025 Seagate Technology Holdings PLC (NASDAQ: STX) has been one of 2025’s standout AI infrastructure winners, but today’s trading shows just how volatile a high-flyer can be once expectations are sky‑high. On Wednesday, December 3, 2025, Seagate shares closed around $258.67, down roughly 3% on the day and marking a third straight session of losses, even as the S&P 500 and Dow both finished higher. MarketWatch Despite the pullback, the stock remains only about 13% below its 52‑week high of $297.88 set on November 12 and is still up well into the triple digits for the year,
3 December 2025
UiPath (PATH) Surges After Q3 Fiscal 2026 Earnings and Guidance Top Wall Street Expectations

UiPath (PATH) Surges After Q3 Fiscal 2026 Earnings and Guidance Top Wall Street Expectations

NEW YORK — December 3, 2025 UiPath Inc. (NYSE: PATH) delivered a stronger-than-expected fiscal third quarter 2026 on Wednesday, posting double‑digit revenue growth, higher‑than‑forecast non‑GAAP earnings, and an upbeat outlook that sent the automation specialist’s shares sharply higher in regular and after‑hours trading. UiPath, Inc.+1 The results mark a key milestone for the company: UiPath reported its first GAAP‑profitable third quarter while continuing to invest heavily in AI‑driven “agentic automation” and an expanding partner ecosystem. UiPath, Inc.+1 Earnings Beat: Revenue, ARR and Profitability All Move Higher For the quarter ended October 31, 2025, UiPath reported: UiPath, Inc.+1 On the bottom line, UiPath reported: UiPath,
Stellantis Stock (STLA) Soars on UBS Upgrade and U.S. Jobs Push: News, Forecasts and Risks on December 3, 2025

Stellantis Stock (STLA) Soars on UBS Upgrade and U.S. Jobs Push: News, Forecasts and Risks on December 3, 2025

Stellantis stock is back on traders’ screens today. On December 3, 2025, shares of Stellantis N.V. (NYSE: STLA) are rallying after a powerful combination of catalysts: a UBS upgrade to “Buy”, fresh details on a major U.S. hiring and investment drive, and a steady stream of regulatory and legal headlines that will shape the automaker’s future. As of the U.S. close, STLA is trading around $11.5 per share, up roughly 4–5% on the day, with a 52‑week range of about $8.39–$14.28. On the Milan exchange, Stellantis is among the top gainers, with the stock jumping around 7–8% to just under
3 December 2025
Mastercard Stock (MA) Today: AI Payments, Analyst Price Targets and 2026 Outlook – December 3, 2025

Mastercard Stock (MA) Today: AI Payments, Analyst Price Targets and 2026 Outlook – December 3, 2025

Published: December 3, 2025 – Information only, not investment advice. Mastercard stock on 3 December 2025: price and market snapshot As of the close on December 3, 2025, Mastercard Incorporated (NYSE: MA) is trading around $553.73 per share, modestly higher on the day and roughly mid‑range in its 52‑week band. Recent filings and price data show: Mastercard also pays a quarterly dividend of $0.76 per share (annualized $3.04, yield close to 0.6%) with a payout ratio under 20%, leaving plenty of room to reinvest in growth while still returning cash to shareholders. MarketBeat Institutional ownership remains extremely high at roughly
Goldman Sachs (GS) Stock on December 3, 2025: Near Record Highs After Dividend Hike, $2 Billion ETF Deal and Mixed 2026 Forecasts

Goldman Sachs (GS) Stock on December 3, 2025: Near Record Highs After Dividend Hike, $2 Billion ETF Deal and Mixed 2026 Forecasts

Data and prices in this article are as of the U.S. close on December 3, 2025. 1. Goldman Sachs stock today: price, valuation and performance The Goldman Sachs Group, Inc. (NYSE: GS) ended trading on December 3, 2025 around $836–837 per share, near its 52‑week high of $841.28. That gives the Wall Street bank a market capitalization of roughly $260 billion, with a trailing P/E near 17x, forward P/E in the mid‑teens, and dividend yield just under 2%. StockAnalysis+1 Over the past year, Goldman Sachs stock has climbed about 36–40%, far outpacing the broader financial sector and the S&P 500.
3 December 2025
Amgen (AMGN) Stock Hits New 52‑Week High as Obesity Drug Bets and Analyst Upgrades Fuel 2025 Rally

Amgen (AMGN) Stock Hits New 52‑Week High as Obesity Drug Bets and Analyst Upgrades Fuel 2025 Rally

Published: December 3, 2025 Amgen Inc. (NASDAQ: AMGN) is closing out 2025 on a powerful upswing. As of the close on December 3, 2025, Amgen shares finished at $345.42, up about 2% on the day, and nudged higher in after-hours trading.StockAnalysis The move pushed the biotech giant to a fresh 52‑week high near $345.95, extending a year-to-date rally of roughly 35%–37% and a one‑year gain of more than 25%.Investing.com+1 Behind the rally is a cluster of catalysts: strong third‑quarter earnings, a deepening obesity drug story around MariTide, aggressive Phase 3 programs, analyst price‑target hikes, and rising institutional ownership. At the
Freeport-McMoRan (FCX) Stock Soars as Copper Rallies but Lawsuits Mount: Latest News and 2026–2027 Outlook (December 3, 2025)

Freeport-McMoRan (FCX) Stock Soars as Copper Rallies but Lawsuits Mount: Latest News and 2026–2027 Outlook (December 3, 2025)

This article is for informational purposes only and does not constitute financial or legal advice. FCX Stock Today: Strong Rebound but Still Below Its Highs On Wednesday, December 3, 2025, Freeport-McMoRan Inc. (NYSE: FCX) closed at $44.53, up 3.63% on the day and comfortably ahead of the broader market, which also posted modest gains. Trading volume hit about 22.8 million shares, above the recent 50‑day average of 20.5 million, underscoring renewed investor interest. Despite the rally, FCX still trades roughly 9.3% below its 52‑week high of $49.12 set on July 8. MarketWatch Fundamentally, FCX remains a large-cap, copper‑levered play: recent
3 December 2025
D-Wave Quantum (QBTS) Stock on December 3, 2025: New U.S. Government Unit, Evercore’s $44 Target and What It Means for Investors

D-Wave Quantum (QBTS) Stock on December 3, 2025: New U.S. Government Unit, Evercore’s $44 Target and What It Means for Investors

As of December 3, 2025, D-Wave Quantum Inc. (NYSE: QBTS) is again at the center of the quantum-computing story on Wall Street. A new U.S. government-focused business unit, a fresh “Outperform” initiation from Evercore ISI with a $44 price target, and a flurry of valuation debates have turned the stock into one of the most closely watched high‑risk tech names on the market. TS2 Tech+2Quantum Zeitgeist+2 Below is a detailed, SEO-friendly rundown of today’s news, analyst forecasts, fundamentals, bull vs. bear arguments, and what could move QBTS next. This article is informational only and not investment advice. Quick Snapshot: QBTS
Eaton Corporation (ETN) Stock Outlook Today: AI Data Centers, Boyd Thermal Deal and 2026 Growth Prospects (3 December 2025)

Eaton Corporation (ETN) Stock Outlook Today: AI Data Centers, Boyd Thermal Deal and 2026 Growth Prospects (3 December 2025)

Eaton Corporation plc (NYSE: ETN) has become one of the most closely watched industrial names in the AI infrastructure boom. As of December 3, 2025, the stock is trading in the mid‑$330s, roughly 17% below its late‑July 52‑week high near $400 after a sharp pullback following earnings and a wave of macro jitters.MarketWatch+1 Yet behind the recent volatility sits a company reporting record results, leaning hard into AI‑driven data centers and grid modernization, and preparing for a major $9.5 billion acquisition that could reshape its role in the cooling side of the data‑center stack.Eaton+1 Below is a deep dive into
3 December 2025
Pfizer Stock (PFE) Today – Price, Metsera Obesity Bet, RSV Vaccine Tailwinds and 2026 Forecast (3 December 2025)

Pfizer Stock (PFE) Today – Price, Metsera Obesity Bet, RSV Vaccine Tailwinds and 2026 Forecast (3 December 2025)

Pfizer Inc. (NYSE: PFE) remains one of the most closely watched healthcare stocks as of December 3, 2025. The share price is still stuck near post‑COVID lows, but a new $10 billion obesity‑drug acquisition, expanding RSV vaccine markets and a hefty dividend yield around 6.5–7% are reshaping the narrative around the stock. Pfizer+2Pfizer+2 Below is a deep dive into where Pfizer stock stands today, which headlines are moving it, and how Wall Street currently values PFE for 2026 and beyond. 1. Pfizer stock today: price, trading range and valuation As of late trading on December 3, 2025, Pfizer shares are
Singapore Stock Market Outlook: 10 Things to Know Before the STI Opens on Thursday, 4 December 2025

Singapore Stock Market Outlook: 10 Things to Know Before the STI Opens on Thursday, 4 December 2025

As Singapore investors wake up for Thursday’s session on 4 December 2025, the Straits Times Index (STI) is coming off a six‑day winning streak, Wall Street has closed higher again, and a rare blockbuster tech‑healthcare IPO has just lit up the SGX board. Here’s a comprehensive look at what’s driving sentiment and which themes may matter when the opening bell rings. 1. STI closes at six‑day high ahead of Thursday’s open Singapore’s benchmark STI finished Wednesday, 3 December, up 16.56 points, or almost 0.4%, at 4,554.52, marking its sixth consecutive gain. The iEdge Singapore Next 50 Index also rose by
3 December 2025
New Zealand Stock Market Outlook for 4 December 2025: 10 Things to Know Before the NZX Opens

New Zealand Stock Market Outlook for 4 December 2025: 10 Things to Know Before the NZX Opens

The New Zealand sharemarket heads into Thursday’s open on the back of a two‑day rally, a fresh Fonterra update, and growing optimism that global central banks are done with aggressive tightening. Here’s a detailed look at what’s likely to shape trading on Thursday, 4 December 2025. Quick snapshot before the bell Below, we unpack the moving parts. 1. How the NZX closed on Wednesday Wednesday’s session on 3 December 2025 set a constructive tone: Key movers: In short, the market is entering Thursday with positive momentum, powered by heavyweights and yield names rather than speculative microcaps. 2. Overnight global leads:
Synopsys (SNPS) Stock on December 3, 2025: Nvidia’s $2 Billion Bet, Class‑Action Lawsuits and New Analyst Forecasts

Synopsys (SNPS) Stock on December 3, 2025: Nvidia’s $2 Billion Bet, Class‑Action Lawsuits and New Analyst Forecasts

Synopsys, Inc. (NASDAQ: SNPS) is back in the market spotlight after a volatile few months. On Wednesday, December 3, 2025, the stock extended a sharp rebound driven by Nvidia’s $2 billion strategic investment, even as fresh class‑action lawsuits and mixed analyst messages kept risks firmly on the radar. As of the U.S. close on December 3, Synopsys shares were trading around the mid‑$460s, up roughly 4% on the day and about 20% above their early‑November lows, but still well below the 52‑week high near $652 reached before the September earnings shock.StockAnalysis+1 Below is a detailed look at what changed on
3 December 2025
Indian Stock Market Today: 10 Things to Know Before Nifty & Sensex Open on December 4, 2025

Indian Stock Market Today: 10 Things to Know Before Nifty & Sensex Open on December 4, 2025

India heads into Thursday’s session (4 December 2025) with equities still hovering near record highs, a currency at historic lows, and a big RBI policy decision just a day away. Here’s a comprehensive pre‑market playbook based on news, data and broker commentary from 3–4 December. Quick snapshot before the opening bell 1. How Dalal Street closed on December 3 Wednesday’s session was another exercise in consolidation near peak territory: Both indices slipped during the day, with Nifty briefly losing the 25,900 zone before last‑hour buying pulled it back. Midcaps and smallcaps underperformed, with broader indices down around 0.7–1%, reflecting profit‑taking
3 December 2025
ASX Opening Preview 4 December 2025: Wall Street Rally, Copper Record and Local Catalysts to Watch Before the Australian Stock Market Opens

ASX Opening Preview 4 December 2025: Wall Street Rally, Copper Record and Local Catalysts to Watch Before the Australian Stock Market Opens

Australian investors head into Thursday’s session with the S&P/ASX 200 sitting just below record territory, global risk assets buoyed by fresh hopes of US rate cuts, and copper and gold trading near all‑time highs. At 7am AEST, ASX futures were pointing to a mildly positive start, up around 0.1%, suggesting a modestly firmer open for the Australian share market on 4 December 2025. Stockhead+1 Below is your comprehensive guide to what happened on the ASX yesterday, what moved overseas markets overnight, and the key data and stock stories likely to shape trading when the opening bell rings. 1. Where the ASX
3 December 2025
Canada Stock Market Today: TSX Climbs on Oil Rally and Bank Earnings After the Bell (Dec. 3, 2025)

Canada Stock Market Today: TSX Climbs on Oil Rally and Bank Earnings After the Bell (Dec. 3, 2025)

Canada’s stock market finished solidly higher on Wednesday, December 3, 2025, as energy names and big banks pulled the S&P/TSX Composite Index out of a brief two‑day slump. After the closing bell, the benchmark index stood at 31,160.54, up 111.26 points (about 0.36%) on the day, according to YCharts and exchange data. YCharts+1 The move tracked a broader risk‑on tone: U.S. stocks also advanced as economic data kept expectations alive for a near‑term Federal Reserve rate cut, helping global equities stabilize after recent jitters around AI spending and tech valuations. Reuters+1 Quick takeaways for investors Let’s unpack what moved Bay Street today, and what that might
3 December 2025
UK Stock Market Opening Preview for 4 December 2025: FTSE 100 Outlook, Key Data and Stocks to Watch

UK Stock Market Opening Preview for 4 December 2025: FTSE 100 Outlook, Key Data and Stocks to Watch

As London investors get ready for the open on Thursday, 4 December 2025, the backdrop is a mix of sluggish UK growth signals, stronger global risk appetite, and intense speculation over interest-rate cuts on both sides of the Atlantic. Here’s a concise but detailed look at what you should know before the bell. 1. How the FTSE 100 Closed on 3 December – and Why It Matters for Tomorrow The FTSE 100 finished Wednesday down around 0.1%, with the mid‑cap FTSE 250 edging up about 0.1%. TradingView The move was modest, but the sector split was anything but: Index reshuffle: WPP out, British Land in The
3 December 2025
US Stock Market Today, December 3, 2025: Dow Jumps 400 Points as Weak Jobs Data Supercharges Fed Cut Bets

US Stock Market Today, December 3, 2025: Dow Jumps 400 Points as Weak Jobs Data Supercharges Fed Cut Bets

U.S. stocks pushed higher after the closing bell on Wednesday, December 3, 2025, with the Dow Jones Industrial Average surging more than 400 points and all major indexes ending near record territory. A surprisingly weak private payrolls report, easing bond yields and resilient services-sector data reinforced expectations that the Federal Reserve will cut interest rates at next week’s policy meeting. WV News+2Reuters+2 Market recap: indexes climb toward record highs By the close of trading: The S&P 500 now sits less than a percentage point below its all‑time high from late October, while the Dow is also within 1% of its own

Stock Market Today

Home Depot stock price: jobs, inflation and a Feb. 24 earnings test loom

Home Depot stock price: jobs, inflation and a Feb. 24 earnings test loom

7 February 2026
Home Depot shares rose 0.7% to $385.15 Friday, trading between $379.10 and $386.37. Investors await a delayed U.S. jobs report Wednesday and CPI data Friday, both postponed by a brief government shutdown. Home Depot reports fourth-quarter earnings Feb. 24. The Dow closed above 50,000 for the first time.
JPMorgan stock price jumps 4% into weekend as Wall Street braces for a busy data week

JPMorgan stock price jumps 4% into weekend as Wall Street braces for a busy data week

7 February 2026
JPMorgan shares rose 3.95% to $322.40 Friday, outpacing other major banks as U.S. stocks rallied and the Dow closed above 50,000 for the first time. The bank recently completed a $3 billion subordinated notes offering. Investors are watching for delayed U.S. jobs data and inflation figures next week, ahead of JPMorgan’s Feb. 23 company update.
AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

7 February 2026
AbbVie shares rose 2% to $223.43 Friday, capping a volatile week marked by earnings and drug sales scrutiny. Moody’s upgraded AbbVie’s credit rating to A2, citing strong performance in immunology and neuroscience. Investors remain focused on Skyrizi and Rinvoq growth amid rising competition and recent regulatory filings. Trading volume stayed below average, with the stock still 9% off its 52-week high.
SK hynix stock price slips into Monday after S&P upgrade, tech selloff

SK hynix stock price slips into Monday after S&P upgrade, tech selloff

7 February 2026
SK hynix shares closed at 839,000 won, down 0.36% Friday and 8% for the week, as tech stocks retreated across Asia. S&P Global Ratings upgraded the chipmaker to “BBB+” with a positive outlook, citing strong HBM sales. The KOSPI fell 1.4% Friday, ending a six-week winning streak. Traders await Monday’s Seoul open for signs of further tech weakness.
Go toTop